Back to search

Ireland· IE-PA-PA23490/032/001

Pepcid AC 10 mg Film-coated Tablets

A famotidine product containing famotidine, registered in Ireland by JNTL Consumer Health I (Ireland) Limited. The same ATC class is registered in 15 of our 19 countries.

ATC A02BA03

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedPepcid AC 10 mg Film-coated TabletsATCA02BA03REGISTER NO.IE-PA-PA23490/032/001PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Famotidine is registered in 15 of 19 countries.

Countries holding a registration under ATC A02BA03 (famotidine), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 8 of them publish a price we can compare per daily dose

Famotidine · ATC A02BA03

15 / 19 countries

  • Canada
  • Czechiaprice
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of famotidine costs, country by country.

Normalised to the WHO defined daily dose (40 mg), the median price runs from $0.26 in Spain to $0.76 in Italy — a ×3.0 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Famotidine · price per daily dose (40 mg)

USD · FX 28 Sept 2026

  • IT Italy$0.76
  • FR France$0.59
  • ES Spain$0.26
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

HPRA (Ireland)
Active substance
Famotidine
Manufacturer
JNTL Consumer Health I (Ireland) Limited
Country
Ireland (IE)
ATC code
A02BA03
ATC class
Famotidine
Defined daily dose
40 mg, O
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA23490/032/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

778 interactions on record for famotidine.

Graded by severity as the source publishes them — 14 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Famotidine · interactions on record

778 records

  • 14 severe
  • 277 moderate
  • 52 minor
  • 434 info

Most severe, free to view

  • AtazanavirJ05AE08severe
  • RilpivirineJ05AG05severe
  • DasatinibL01EA02severe
  • NeratinibL01EH02severe

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Famotidine in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All famotidine products

Authorised across Europe · EMA

The same active substance is authorised in 24 EEA countries. Names it is sold under:

  • Austria · Famosin, Famotidin !$tada
  • Bulgaria · Famore 20 Mg, Famore 40 Mg
  • Cyprus · Famopsin, Ulcedine
  • Czechia · Famosan, Kuladgy
  • Germany · Famotidin Ratiopharm, Famotidin Stada
  • Estonia · Kuladgy
  • Spain · Famotidina Aristo, Famotidina Cinfa
  • Finland · Pepcid
  • France · Famotidine Eg, Famotidine Eg Labo
  • United Kingdom (Northern Ireland) · Famotidine Alissa Healthcare Research, Famotidine Celix Pharma
  • Greece · Banatin, Famotidine Beλκα Ελλασ
  • Croatia · Confamo, Famosan
  • Hungary · Apo-Famotidin, Motidin
  • Italy · Famotidina Doc, Famotidina Eg
  • Lithuania · Kuladgy, Quamatel
  • Latvia · Kuladgy, Quamatel
  • Malta · Famotidine Clonmel Healthcare
  • Netherlands · Famotidine Aurobindo, Famotidine Centrafarm
  • Norway · Famotidin Vivanta, Pepcid
  • Poland · Famiflux, Famogast
  • Portugal · Lasa
  • Romania · Famodin, Famotidină Zentiva
  • Sweden · Famotidin Vivanta, Pepcid
  • Slovakia · Famosan, Famotidin Sl Zentiva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f87ff637-2a97-4196-ad16-868c45aaeeeb
GET /v1/drugs/f87ff637-2a97-4196-ad16-868c45aaeeeb?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "A02BA",
    "A02BA03"
  ],
  "strength": null,
  "pa_number": "PA23490/032/001",
  "substances": [
    "Famotidine"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "24/09/1996",
  "dispensing_status": "Product not subject to medical prescription",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about famotidine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.